Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-20-007366
Filing Date
2020-08-19
Accepted
2020-08-19 08:55:53
Documents
1
Period of Report
2020-08-18

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-49485.html 4  
1 PRIMARY DOCUMENT marketforms-49485.xml 4 3385
  Complete submission text file 0001214659-20-007366.txt   4790
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Issuer) CIK: 0001398733 (see all company filings)

EIN.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address
Maxwell John T. (Reporting) CIK: 0001739025 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38599 | Film No.: 201115416